CH650802A5 - Production d'hormone de croissance humaine. - Google Patents
Production d'hormone de croissance humaine. Download PDFInfo
- Publication number
- CH650802A5 CH650802A5 CH4866/81A CH486681A CH650802A5 CH 650802 A5 CH650802 A5 CH 650802A5 CH 4866/81 A CH4866/81 A CH 4866/81A CH 486681 A CH486681 A CH 486681A CH 650802 A5 CH650802 A5 CH 650802A5
- Authority
- CH
- Switzerland
- Prior art keywords
- cells
- human
- growth hormone
- hgh
- production
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 25
- 102000002265 Human Growth Hormone Human genes 0.000 title claims description 5
- 108010000521 Human Growth Hormone Proteins 0.000 title claims description 5
- 239000000854 Human Growth Hormone Substances 0.000 title claims description 5
- 210000004027 cell Anatomy 0.000 claims description 67
- 241001465754 Metazoa Species 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 27
- 210000005260 human cell Anatomy 0.000 claims description 23
- 208000005310 acidophil adenoma Diseases 0.000 claims description 13
- 102000018997 Growth Hormone Human genes 0.000 claims description 12
- 108010051696 Growth Hormone Proteins 0.000 claims description 12
- 239000000122 growth hormone Substances 0.000 claims description 12
- 239000000411 inducer Substances 0.000 claims description 12
- 241000700159 Rattus Species 0.000 claims description 7
- 238000009792 diffusion process Methods 0.000 claims description 7
- 210000001124 body fluid Anatomy 0.000 claims description 6
- 239000010839 body fluid Substances 0.000 claims description 6
- 230000000050 nutritive effect Effects 0.000 claims description 6
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 5
- 241000699800 Cricetinae Species 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 3
- 230000007910 cell fusion Effects 0.000 claims description 3
- 210000004408 hybridoma Anatomy 0.000 claims description 3
- 239000004475 Arginine Substances 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims description 2
- 241000283707 Capra Species 0.000 claims description 2
- 241000700199 Cavia porcellus Species 0.000 claims description 2
- 241000282693 Cercopithecidae Species 0.000 claims description 2
- 241000272201 Columbiformes Species 0.000 claims description 2
- 241000283073 Equus caballus Species 0.000 claims description 2
- 241000282326 Felis catus Species 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 241000009328 Perro Species 0.000 claims description 2
- 241000282898 Sus scrofa Species 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 239000002207 metabolite Substances 0.000 claims description 2
- 244000144977 poultry Species 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 229940076279 serotonin Drugs 0.000 claims description 2
- 239000005556 hormone Substances 0.000 claims 2
- 229940088597 hormone Drugs 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 230000001817 pituitary effect Effects 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 239000006285 cell suspension Substances 0.000 description 14
- 238000000338 in vitro Methods 0.000 description 12
- 238000002054 transplantation Methods 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 9
- 230000036046 immunoreaction Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical class OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 241000711408 Murine respirovirus Species 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 210000003635 pituitary gland Anatomy 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 208000003200 Adenoma Diseases 0.000 description 1
- 206010001233 Adenoma benign Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 210000004198 anterior pituitary gland Anatomy 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 201000005296 lung carcinoma Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 208000021310 pituitary gland adenoma Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55105273A JPS6045848B2 (ja) | 1980-07-31 | 1980-07-31 | ヒト成長ホルモンの製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH650802A5 true CH650802A5 (fr) | 1985-08-15 |
Family
ID=14403051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH4866/81A CH650802A5 (fr) | 1980-07-31 | 1981-07-27 | Production d'hormone de croissance humaine. |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS6045848B2 (ko) |
KR (1) | KR860000895B1 (ko) |
CH (1) | CH650802A5 (ko) |
FR (1) | FR2487852A1 (ko) |
GB (1) | GB2083824B (ko) |
IT (1) | IT1142590B (ko) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58138395A (ja) * | 1982-02-12 | 1983-08-17 | Hayashibara Biochem Lab Inc | ヒト免疫応答抑制因子の製造方法 |
FR2523155B1 (fr) * | 1982-03-11 | 1987-10-16 | Hayashibara Biochem Lab | Preparation de facteur de croissance des cellules t humaines |
BG49718A3 (en) * | 1983-07-15 | 1992-01-15 | Bio- Technology General Corp | Method for preparing of polypeptid with superoxiddismutasne activitty |
FR2565995B1 (fr) * | 1984-03-07 | 1987-10-23 | Centre Nat Rech Scient | Cellules hybrides productrices d'un polypeptide determine et obtenu a partir de cellules primaires naturellement capables d'exprimer ce polypeptide ou un polypeptide equivalent, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production dudit polypeptide |
FR2581393B2 (fr) * | 1985-05-02 | 1989-07-21 | Grp Genie Genetique | Cellules hybrides productrices d'un antigene caracteristique du virus de l'hepatite b obtenu a partir d'hepatocytes et de cellules etablies de singe, procede pour l'obtention de ces cellules hybrides et application de celles-ci a la production de l'antigene susdit |
FR2596414B1 (fr) * | 1986-03-28 | 1989-10-06 | Pasteur Institut | Hybridomes obtenus a partir de lymphocytes d'animaux transgeniques portant un gene exprimant une proteine donnee et procede de preparation d'une telle proteine a partir de tels hybridomes |
JP4855803B2 (ja) * | 2006-02-28 | 2012-01-18 | 株式会社フクダ産業 | 呼吸機能検査装置 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4124448A (en) * | 1976-04-09 | 1978-11-07 | The Regents Of The University Of Minnesota | Process for the large scale production of human growth hormone by serial secondary suspension culture |
GB2016015B (en) * | 1978-01-22 | 1982-05-06 | Hayashibara Co | Method of preparing interferon and preparations containing interferon |
-
1980
- 1980-07-31 JP JP55105273A patent/JPS6045848B2/ja not_active Expired
-
1981
- 1981-07-22 IT IT48956/81A patent/IT1142590B/it active
- 1981-07-23 KR KR1019810002669A patent/KR860000895B1/ko not_active IP Right Cessation
- 1981-07-24 GB GB8122891A patent/GB2083824B/en not_active Expired
- 1981-07-27 CH CH4866/81A patent/CH650802A5/fr not_active IP Right Cessation
- 1981-07-27 FR FR8114524A patent/FR2487852A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
GB2083824B (en) | 1984-01-11 |
GB2083824A (en) | 1982-03-31 |
KR830005868A (ko) | 1983-09-14 |
FR2487852A1 (fr) | 1982-02-05 |
IT1142590B (it) | 1986-10-08 |
FR2487852B1 (ko) | 1984-12-14 |
JPS5731622A (en) | 1982-02-20 |
IT8148956A0 (it) | 1981-07-22 |
JPS6045848B2 (ja) | 1985-10-12 |
KR860000895B1 (ko) | 1986-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH650024A5 (fr) | Procede pour la production d'erythropoietine humaine. | |
CH653364A5 (fr) | Procede pour la production du facteur de croissance epidermique humain. | |
CH649786A5 (fr) | Production de facteur leucopoietique humain. | |
EP1149899B1 (fr) | Milieu de culture de cellules embryonnaires totipotentes aviaires | |
CH650023A5 (fr) | Production d'hormone humaine stimulant les follicules. | |
CH649782A5 (fr) | Procede pour la production d'insuline humaine. | |
CH649785A5 (fr) | Production d'hormone luteinisante humaine. | |
FR2495635A1 (fr) | Production d'urokinase humaine | |
CH649784A5 (fr) | Procede pour la production de gonadotrophine chorionique humaine. | |
CH650802A5 (fr) | Production d'hormone de croissance humaine. | |
CH664969A5 (fr) | Lymphokine humain, sa production et son utilisation pour obtenir un anticorps monoclonal specifique de ce lymphokine. | |
CH652748A5 (fr) | Production d'hormone parathyroidienne humaine. | |
CH652749A5 (fr) | Production de calcitonine humaine. | |
CH652750A5 (fr) | Production de facteur de croissance humain. | |
FR2615737A1 (fr) | Preparation et utilisation d'interferon-gamma | |
CH649783A5 (fr) | Procede pour la production de prolactine humaine. | |
CH652747A5 (fr) | Production d'hormone de stimulation de la thyroide humaine. | |
FR2572936A1 (fr) | Nouveau lymphokine et anticorps monoclonal specifique de ce lymphokine, leurs production et utilisations | |
EP4166653A1 (fr) | Modèle d'étude animal du cancer | |
CH652745A5 (fr) | Procede pour la production d'hormone adrenocorticotrope humaine. | |
CH652746A5 (fr) | Production d'hormone lactogene, placentaire, humaine. | |
CH661745A5 (fr) | Application d'un procede a la production de suppresseur de reponse immunitaire humain. | |
CH658668A5 (fr) | Procede pour la production de kallikreine humaine. | |
FR2523155A1 (fr) | Preparation de facteur de croissance des cellules t humaines | |
CH651588A5 (en) | Preparation of human T cell growth factor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |